Skip to main content
Log in

Profound Effect of Plasma Protein Binding on the Polarized Transport of Furosemide and Verapamil in the Caco-2 Model

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. F. Delie and W. Rubas. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14:221-286 (1997).

    Google Scholar 

  2. E. Liang, K. Chessic, and M. Yazdanian. Evaluation of an accelerated Caco-2 cell permeability model. J. Pharm. Sci. 89:336-345 (2000).

    Google Scholar 

  3. J. H. Hochman, M. Chiba, J. Nishime, M. Yamazaki, and J. H. Lin. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4. J. Pharmacol. Exp. Ther. 292:310-318 (2000).

    Google Scholar 

  4. P. Artursson and R. T. Borchardt. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 14:1655-1658 (1997).

    Google Scholar 

  5. V. Pade and S. Stavchansky. Link between drug absorption solubility and permeability measurements in Caco-2 cells. J. Pharm. Sci. 87:1604-1607 (1998).

    Google Scholar 

  6. S. D. Flanagan and L. Z. Benet. Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2monolayers and excised rat jejunum. Pharm. Res. 16:221-224 (1999).

    Google Scholar 

  7. L. Z. Benet and C. Y. Wu: Method for increasing bioavailability of oral pharmaceutical compositions. United States Patent #6028054, February 22, 2000.

    Google Scholar 

  8. M. A. Gibbs, M. T. Baillie, D. D. Shen, K. L. Kunze, and K. E. Thummel. Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells. Pharm. Res. 17:299-305 (2000).

    Google Scholar 

  9. W. L. Chiou. We may not measure the correct intestinal wall permeability coefficient of drugs: Alternative absorptive clearance concept. J. Pharmacokinet. Biopharm. 23:323-331 (1995).

    Google Scholar 

  10. W. L. Chiou. Commentary: New perspectives on the theory of permeability and resistance in the study of drug transport and absorption. J. Pharmacokinet. Biopharm. 24:433-42 (1996).

    Google Scholar 

  11. V. D. Makhey, A. Guo, D. A. Norris, P. Hu, J. Yan, and P. J. Sinko. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15:1160-1167 (1998).

    Google Scholar 

  12. L. Z. Benet, S. Øie, and J. B. Schwarts. Design and Optimization of dosage regimens; Pharmacokinetic data. In A. Goodman Gilman, J. G. Hardman, L. E. Limbard, P. B. Molinoff, and R. W. Ruddon (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edition, McGraw Hill, NY, 1996 pp. 1707-1792.

    Google Scholar 

  13. M. G. Lee and W. L. Chiou. Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism. J. Pharmacokinet. Biopharm. 11:623-640 (1983).

    Google Scholar 

  14. P. Manitpisitkul and W. L. Chiou. Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans. Biopharm. Drug. Dispos. 14:555-566 (1993).

    Google Scholar 

  15. G. A. Sawada, N. F. H. Ho, L. R. Williams, C. L. Barsuhn, and T. J. Raub. Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning. Pharm. Res. 11:665-673 (1994).

    Google Scholar 

  16. R. K. Verbeeck, J. A. Cardinal, A. G. Hill, and K. K. Midha. Binding of phenothiazine neuroleptics to plasma proteins. Biochem. Pharmacol. 32:2565-2570 (1983).

    Google Scholar 

  17. Y. Imamura and H. Ichibagase. Effect of simultaneous administration of drugs on absorption and excretion. VIII. Effect of plasma-protein binding displacement on the intestinal absorption of sulfonamides in rabbits. Chem. Pharm. Bull. 25:3400-3405 (1977).

    Google Scholar 

  18. W. L. Chiou. Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration. Int. J. Clin. Pharmacol. Ther. 32:474-82 (1994).

    Google Scholar 

  19. R. A. Walgren and T. Walle. The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption. J. Pharm. Pharmacol. 51:1037-1040 (1999).

    Google Scholar 

  20. W. L. Chiou and F. H. Hsu. Correlation of unbound plasma clearances of fifteen extensively metabolized drugs between humans and rats. Pharm. Res. 5:668-672 (1988).

    Google Scholar 

  21. W. L. Chiou, S. M. Chung, and T. C. Wu. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice. Pharm. Res. 17:205-208 (2000).

    Google Scholar 

  22. S. M. Chung and W. L. Chiou. Potential overestimation of the role of gastrointestinal metabolism and p-glycoprotein mediated efflux in contributing to low bioavailability of drugs in humans. PharmSci Suppl. 1:Presentation 4272 (1999).

    Google Scholar 

  23. Physicians' Desk Reference, 54th edition, Medical Economics Company, Montvale, NJ, 2000.

  24. H. J. Kuhnel, K. Gunther, G. Stein, and A. Hoffmann-Traeger. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome. Int. J. Clin. Pharmacol. Ther. Toxicol. 25:616-621 (1987).

    Google Scholar 

  25. R. Sandstrom, T. W. Knutson, L. Knutson, B. Jansson, and H. Lennernäs. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. Br. J. Clin. Pharmacol. 48:180-189 (1999).

    Google Scholar 

  26. W. L. Chiou, S. M. Chung, T. C. Wu, and C. Ma. Commentary: A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. Int. J. Clin. Pharmacol. Ther. (March, 2001).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chung, S.M., Park, E.J., Swanson, S.M. et al. Profound Effect of Plasma Protein Binding on the Polarized Transport of Furosemide and Verapamil in the Caco-2 Model. Pharm Res 18, 544–547 (2001). https://doi.org/10.1023/A:1011022931368

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011022931368

Navigation